[GENTING] QoQ Annualized Quarter Result on 31-Mar-2011 [#1]

Announcement Date
26-May-2011
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2011
Quarter
31-Mar-2011 [#1]
Profit Trend
QoQ- 49.65%
YoY- 254.58%
View:
Show?
Annualized Quarter Result
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
Revenue 18,580,142 18,348,181 18,703,930 19,556,632 15,194,737 14,810,697 14,397,628 18.47%
PBT 6,364,744 6,184,318 6,878,156 7,562,596 4,394,324 4,282,065 3,586,312 46.43%
Tax -1,219,563 -1,210,773 -1,590,860 -1,778,396 -983,625 -809,366 -822,718 29.91%
NP 5,145,181 4,973,545 5,287,296 5,784,200 3,410,699 3,472,698 2,763,594 51.16%
-
NP to SH 2,867,501 2,792,784 2,994,792 3,296,704 2,202,957 2,316,698 1,943,212 29.52%
-
Tax Rate 19.16% 19.58% 23.13% 23.52% 22.38% 18.90% 22.94% -
Total Cost 13,434,961 13,374,636 13,416,634 13,772,432 11,784,038 11,337,998 11,634,034 10.04%
-
Net Worth 17,644,453 16,955,130 16,781,802 16,150,145 15,458,049 14,972,281 13,864,240 17.38%
Dividend
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
Div 295,923 172,759 259,321 - 288,451 162,661 244,010 13.68%
Div Payout % 10.32% 6.19% 8.66% - 13.09% 7.02% 12.56% -
Equity
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
Net Worth 17,644,453 16,955,130 16,781,802 16,150,145 15,458,049 14,972,281 13,864,240 17.38%
NOSH 3,699,046 3,701,993 3,704,591 3,704,161 3,698,098 3,696,859 3,697,130 0.03%
Ratio Analysis
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
NP Margin 27.69% 27.11% 28.27% 29.58% 22.45% 23.45% 19.19% -
ROE 16.25% 16.47% 17.85% 20.41% 14.25% 15.47% 14.02% -
Per Share
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
RPS 502.30 495.63 504.89 527.96 410.88 400.63 389.43 18.43%
EPS 77.52 75.44 80.84 89.00 59.57 62.67 52.56 29.47%
DPS 8.00 4.67 7.00 0.00 7.80 4.40 6.60 13.64%
NAPS 4.77 4.58 4.53 4.36 4.18 4.05 3.75 17.34%
Adjusted Per Share Value based on latest NOSH - 3,704,161
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
RPS 482.35 476.33 485.56 507.70 394.46 384.49 373.77 18.47%
EPS 74.44 72.50 77.75 85.58 57.19 60.14 50.45 29.51%
DPS 7.68 4.48 6.73 0.00 7.49 4.22 6.33 13.71%
NAPS 4.5806 4.4016 4.3566 4.1927 4.013 3.8869 3.5992 17.38%
Price Multiplier on Financial Quarter End Date
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
Date 30/12/11 30/09/11 30/06/11 31/03/11 30/12/10 30/09/10 30/06/10 -
Price 11.00 9.10 11.22 11.04 11.18 9.92 7.12 -
P/RPS 2.19 1.84 2.22 2.09 2.72 2.48 1.83 12.68%
P/EPS 14.19 12.06 13.88 12.40 18.77 15.83 13.55 3.11%
EY 7.05 8.29 7.20 8.06 5.33 6.32 7.38 -2.99%
DY 0.73 0.51 0.62 0.00 0.70 0.44 0.93 -14.86%
P/NAPS 2.31 1.99 2.48 2.53 2.67 2.45 1.90 13.87%
Price Multiplier on Announcement Date
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
Date 28/02/12 24/11/11 25/08/11 26/05/11 23/02/11 25/11/10 26/08/10 -
Price 10.54 10.28 9.78 11.10 10.38 10.40 9.00 -
P/RPS 2.10 2.07 1.94 2.10 2.53 2.60 2.31 -6.14%
P/EPS 13.60 13.63 12.10 12.47 17.42 16.60 17.12 -14.18%
EY 7.35 7.34 8.27 8.02 5.74 6.03 5.84 16.52%
DY 0.76 0.45 0.72 0.00 0.75 0.42 0.73 2.71%
P/NAPS 2.21 2.24 2.16 2.55 2.48 2.57 2.40 -5.33%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment